114 related articles for article (PubMed ID: 24979950)
21. Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
Cleary JD; Garcia-Effron G; Chapman SW; Perlin DS
Antimicrob Agents Chemother; 2008 Jun; 52(6):2263-5. PubMed ID: 18378714
[TBL] [Abstract][Full Text] [Related]
22. Set of classical PCRs for detection of mutations in Candida glabrata FKS genes linked with echinocandin resistance.
Dudiuk C; Gamarra S; Leonardeli F; Jimenez-Ortigosa C; Vitale RG; Afeltra J; Perlin DS; Garcia-Effron G
J Clin Microbiol; 2014 Jul; 52(7):2609-14. PubMed ID: 24829248
[TBL] [Abstract][Full Text] [Related]
23. New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium species.
Johnson ME; Katiyar SK; Edlind TD
Antimicrob Agents Chemother; 2011 Aug; 55(8):3774-81. PubMed ID: 21576441
[TBL] [Abstract][Full Text] [Related]
24. In vitro antifungal susceptibility of Candida glabrata to caspofungin and the presence of FKS mutations correlate with treatment response in an immunocompromised murine model of invasive infection.
Fernández-Silva F; Lackner M; Capilla J; Mayayo E; Sutton D; Castanheira M; Fothergill AW; Lass-Flörl C; Guarro J
Antimicrob Agents Chemother; 2014 Jul; 58(7):3646-9. PubMed ID: 24733474
[TBL] [Abstract][Full Text] [Related]
25. Rapid Detection of FKS-Associated Echinocandin Resistance in Candida glabrata.
Zhao Y; Nagasaki Y; Kordalewska M; Press EG; Shields RK; Nguyen MH; Clancy CJ; Perlin DS
Antimicrob Agents Chemother; 2016 Nov; 60(11):6573-6577. PubMed ID: 27550360
[TBL] [Abstract][Full Text] [Related]
26. Analysis of fks1 and fks2 gene mutations in invasive Candida glabrata strains from Pakistan.
Memon S; Ghanchi NK; Zafar U; Farooqi J; Zaka S; Jabeen K
Mycoses; 2023 Jan; 66(1):52-58. PubMed ID: 36106428
[TBL] [Abstract][Full Text] [Related]
27. Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.
Klotz U; Schmidt D; Willinger B; Steinmann E; Buer J; Rath PM; Steinmann J
Mycoses; 2016 May; 59(5):312-8. PubMed ID: 26806376
[TBL] [Abstract][Full Text] [Related]
28. Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong
Schell WA; Jones AM; Garvey EP; Hoekstra WJ; Schotzinger RJ; Alexander BD
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956419
[TBL] [Abstract][Full Text] [Related]
29. Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata.
Bordallo-Cardona MÁ; Escribano P; Marcos-Zambrano LJ; Díaz-García J; de la Pedrosa EG; Cantón R; Bouza E; Guinea J
Med Mycol; 2018 Oct; 56(7):903-906. PubMed ID: 29228268
[TBL] [Abstract][Full Text] [Related]
30.
Jiménez-Ortigosa C; Perez WB; Angulo D; Borroto-Esoda K; Perlin DS
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630180
[TBL] [Abstract][Full Text] [Related]
31. Mutant Prevention Concentration and Mutant Selection Window of Micafungin and Anidulafungin in Clinical Candida glabrata Isolates.
Bordallo-Cardona MÁ; Marcos-Zambrano LJ; Sánchez-Carrillo C; de la Pedrosa EGG; Cantón R; Bouza E; Escribano P; Guinea J
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311063
[TBL] [Abstract][Full Text] [Related]
32. Breakthrough candidemia due to multidrug-resistant Candida glabrata during prophylaxis with a low dose of micafungin.
Bizerra FC; Jimenez-Ortigosa C; Souza AC; Breda GL; Queiroz-Telles F; Perlin DS; Colombo AL
Antimicrob Agents Chemother; 2014; 58(4):2438-40. PubMed ID: 24468776
[TBL] [Abstract][Full Text] [Related]
33. Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection.
Shields RK; Nguyen MH; Press EG; Cumbie R; Driscoll E; Pasculle AW; Clancy CJ
Antimicrob Agents Chemother; 2015 Dec; 59(12):7465-70. PubMed ID: 26392494
[TBL] [Abstract][Full Text] [Related]
34. Echinocandin Resistance in Candida.
Perlin DS
Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S612-7. PubMed ID: 26567278
[TBL] [Abstract][Full Text] [Related]
35. Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemia.
Imbert S; Castain L; Pons A; Jacob S; Meyer I; Palous M; Vezinet C; Langeron O; Hennequin C; Monsel A; Fekkar A
Clin Microbiol Infect; 2016 Oct; 22(10):891.e5-891.e8. PubMed ID: 27484020
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic and Molecular Evaluation of Echinocandin Susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis Strains Isolated during 30 Years in Argentina.
Morales-López S; Dudiuk C; Vivot W; Szusz W; Córdoba SB; Garcia-Effron G
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461313
[TBL] [Abstract][Full Text] [Related]
37. Antifungal resistance does not necessarily affect Candida glabrata fitness.
Borghi E; Andreoni S; Cirasola D; Ricucci V; Sciota R; Morace G
J Chemother; 2014 Feb; 26(1):32-6. PubMed ID: 24091025
[TBL] [Abstract][Full Text] [Related]
38. Comparison of fks gene mutations and minimum inhibitory concentrations for the detection of Candida glabrata resistance to micafungin: A systematic review and meta-analysis.
Bienvenu AL; Leboucher G; Picot S
Mycoses; 2019 Sep; 62(9):835-846. PubMed ID: 31077631
[TBL] [Abstract][Full Text] [Related]
39. FKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy.
Costa-de-Oliveira S; Marcos Miranda I; Silva RM; Pinto E Silva A; Rocha R; Amorim A; Gonçalves Rodrigues A; Pina-Vaz C
Antimicrob Agents Chemother; 2011 Mar; 55(3):1312-4. PubMed ID: 21149621
[TBL] [Abstract][Full Text] [Related]
40. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
Nagayoshi Y; Miyazaki T; Shimamura S; Nakayama H; Minematsu A; Yamauchi S; Takazono T; Nakamura S; Yanagihara K; Kohno S; Mukae H; Izumikawa K
PLoS One; 2017; 12(7):e0180990. PubMed ID: 28700656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
